Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan haemodynamic effects in elective AVR plus CABG surgery
2008-001672-70Phase 4Completed
- Sponsor
- Heli Leppikangas
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan in aortic valve disease (AVD) and coronary arteriosclerosis, sponsored by Heli Leppikangas. Started Apr 2008; status: completed.
02
Drugs
levosimendan
03
Conditions
aortic valve disease (AVD)coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-001672-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001672-70.